Study of toxoplasma DNA in blood without symptoms
Part of Infections clinical trials.
This study looks at people who have a positive blood test for toxoplasma DNA but no symptoms of toxoplasmosis. It aims to understand the meaning of an isolated positive PCR result.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a positive blood test for toxoplasma DNA during the study period.
- You must not have any symptoms of toxoplasmosis since your last negative blood test.
- You must not have had a positive toxoplasma test in any body fluid or tissue in the last 6 weeks.
- You cannot have a false-positive result due to lab error.
- You must have a known immune status against toxoplasma and be immune.
- Your blood tests must not suggest active or recent toxoplasma infection.
- You cannot have congenital, eye, or HIV-related toxoplasmosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with severe toxoplasmosis (a parasitic infection) that affects the brain or spreads in the body, and who need intensive care, recover. It uses a sensitive test called PCR to confirm the infection.
This study looks at tiny molecules in the blood (called microRNAs) that might help doctors tell the difference between mental health conditions in women who have had a past infection with the parasite Toxoplasma. The goal is to find better ways to diagnose and treat these conditions.
This study tests a combination of three medications (pyrimethamine, sulfadiazine, and leucovorin) to treat toxoplasmosis—a parasitic infection passed from mother to baby during pregnancy. The goal is to see if early treatment prevents serious complications in infected infants.
This study looks at toxoplasmosis infections in people with weakened immune systems (not caused by HIV). It aims to learn more about how these infections happen and how they affect patients.
This study checks whether a simple “point-of-care” test can detect current or past Toxoplasmosis infection (a common germ). Your results may help evaluate how well the test works and how it could be used in care.
This trial is testing new rapid diagnostic tests to detect infection with Trypanosoma cruzi, which causes Chagas disease. It aims to find faster ways to diagnose people who may be at risk, such as pregnant women, blood donors, or those with possible chronic infection.
Hear when a new Toxoplasmosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.